CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) of 4.5 year for the 12-month period ending 2012-12-29, per its 10-K filed 2013-02-27.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm · last filed 2013-02-27
- 2011-06-25: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) 6 month 420.00%.
- 2010-06-26: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) 6 month 450.00%.
pure
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) 6 month |
|---|---|
| 2011-06-25 | 420.00% 10-Q · filed 2011-08-03 |
| 2010-06-26 | 450.00% 10-Q · filed 2011-08-03 |
Y
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) 9 month |
|---|---|
| 2011-09-24 | 4.20 Y 10-Q · filed 2011-11-02 |
| 2010-09-25 | 4.50 Y 10-Q · filed 2011-11-02 |
year
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-12-29 | 4.50 year 10-K · filed 2013-02-27 | |||
| 2012-09-29 | 4.50 year 10-Q · filed 2012-11-01 | |||
| 2012-06-30 | 4.50 year 10-Q · filed 2012-08-07 | |||
| 2012-03-31 | 4.50 year 10-Q · filed 2012-05-04 | |||
| 2011-12-31 | 4.20 year 10-K · filed 2013-02-27 | |||
| 2011-09-24 | 4.20 year 10-Q · filed 2012-11-01 | |||
| 2011-06-25 | 4.20 year 10-Q · filed 2012-08-07 | |||
| 2011-03-26 | 4.20 year 10-Q · filed 2012-05-04 | |||
| 2010-12-25 | 4.50 year 10-K · filed 2013-02-27 | |||
| 2009-12-26 | 4.50 year 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |